Correlation Between Arcus Biosciences and Karuna Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Arcus Biosciences and Karuna Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcus Biosciences and Karuna Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arcus Biosciences and Karuna Therapeutics, you can compare the effects of market volatilities on Arcus Biosciences and Karuna Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcus Biosciences with a short position of Karuna Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcus Biosciences and Karuna Therapeutics.

Diversification Opportunities for Arcus Biosciences and Karuna Therapeutics

0.29
  Correlation Coefficient

Modest diversification

The 3 months correlation between Arcus and Karuna is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Arcus Biosciences and Karuna Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Karuna Therapeutics and Arcus Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcus Biosciences are associated (or correlated) with Karuna Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Karuna Therapeutics has no effect on the direction of Arcus Biosciences i.e., Arcus Biosciences and Karuna Therapeutics go up and down completely randomly.

Pair Corralation between Arcus Biosciences and Karuna Therapeutics

If you would invest  1,557  in Arcus Biosciences on September 1, 2024 and sell it today you would lose (13.00) from holding Arcus Biosciences or give up 0.83% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy0.37%
ValuesDaily Returns

Arcus Biosciences  vs.  Karuna Therapeutics

 Performance 
       Timeline  
Arcus Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Arcus Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Arcus Biosciences is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.
Karuna Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Karuna Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Karuna Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Arcus Biosciences and Karuna Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Arcus Biosciences and Karuna Therapeutics

The main advantage of trading using opposite Arcus Biosciences and Karuna Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcus Biosciences position performs unexpectedly, Karuna Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Karuna Therapeutics will offset losses from the drop in Karuna Therapeutics' long position.
The idea behind Arcus Biosciences and Karuna Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Technical Analysis
Check basic technical indicators and analysis based on most latest market data